Alujain Corp

Alujain Corp maintains a strong liquidity position, with a current ratio of 3.57 and cash and equivalents amounting to SAR 1.03 billion, which is significantly higher than the industry median for liquidity. The company's debt-to-equity ratio is 0.01, indicating a conservative capital structure with minimal leverage.

Profitability metrics show that Alujain Corp's return on equity (ROE) is 0.41%, and return on assets (ROA) is 0.26%. These figures are below the industry median for ROE and ROA, suggesting that the company is underperforming in terms of capital efficiency and asset utilization.

The company's revenue is concentrated in the chemicals segment, with no disclosed geographic diversification. This concentration increases exposure to sector-specific risks, such as commodity price volatility and demand fluctuations in the industrial and manufacturing sectors.

Looking ahead, Alujain Corp is projected to experience modest revenue growth, with a capital expenditure of SAR -190.13 million in the latest period. The company's free cash flow is SAR 6.52 million, which is relatively low compared to its operating cash flow of SAR 123.54 million, indicating that capital expenditures are consuming a significant portion of cash flow.

Risk factors for Alujain Corp include low liquidity risk and low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's conservative capital structure and strong cash reserves mitigate liquidity concerns, while the absence of dilution risk suggests that the company is not planning significant equity issuances in the near term.

Recent events include a consistent analyst price target of SAR 34.00, with a mean recommendation of 2.00 (indicating a "buy" rating). The lack of strong-buy ratings and the presence of only one buy recommendation suggest a cautious outlook from analysts.

Alujain Corp trades at a 17.7% discount to the consensus price target of SAR 34.00, indicating significant upside potential.

The company maintains a minimal debt-to-equity ratio of 0.01, placing it in the top quartile for financial leverage safety.

Cash conversion metrics rank as best-in-class within the cohort, significantly outperforming the median benchmark of 1.1.

The company faces low levels of dilution, liquidity, and credit risk, suggesting a stable financial foundation despite recent volatility.

Return on equity of 0.41% falls drastically below the cohort median of 3.61%, reflecting poor capital efficiency.

Net margins of 3.8% trail the Commodity Chemicals cohort median of 4.17%, suggesting weaker bottom-line performance than peers.

Capital expenditure intensity reached -49.9% of revenue, placing the company in the bottom quartile for capital efficiency.

Revenue SAR 1.30B, −16,3% YoY; Operating income −1 182,7% YoY.

• ▍Revenue SAR 1.30B, −16,3% YoY
• ▍Operating income −1 182,7% YoY
• ▍Net income −1 544,6% YoY
• ▍Free cash flow −279,9% YoY
• ▍Net margin -64.1%

Revenue SAR 1.56B, +11,3% YoY; Operating income −662,9% YoY.

• ▍Revenue SAR 1.56B, +11,3% YoY
• ▍Operating income −662,9% YoY
• ▍Net income +38,4% YoY
• ▍Free cash flow −8 892,2% YoY
• ▍Net margin -3.3%

Revenue SAR 1.40B, −26,9% YoY; Operating income −88,8% YoY.

• ▍Revenue SAR 1.40B, −26,9% YoY
• ▍Operating income −88,8% YoY
• ▍Net income −227,4% YoY
• ▍Free cash flow −96,6% YoY
• ▍Net margin -5.9%